Aspira Women's Health Appoints New CMO, Adds Director
Ticker: AWHL · Form: 8-K · Filed: Jun 7, 2024 · CIK: 926617
| Field | Detail |
|---|---|
| Company | Aspira Women'S Health INC. (AWHL) |
| Form Type | 8-K |
| Filed Date | Jun 7, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $375,000, $325,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, board-changes, governance
TL;DR
Aspira Women's Health brings in a new CMO and adds a director to the board.
AI Summary
Aspira Women's Health Inc. announced on June 6, 2024, the appointment of Dr. Carolann M. Small as Chief Medical Officer and the election of Ms. Jennifer L. Good to its Board of Directors. The company also disclosed compensatory arrangements for certain officers, details of which are included in the filing.
Why It Matters
The appointment of a new Chief Medical Officer and a new board member can signal strategic shifts or a renewed focus on medical innovation and governance for Aspira Women's Health.
Risk Assessment
Risk Level: low — This filing primarily concerns executive appointments and board changes, which are routine corporate governance events.
Key Players & Entities
- Aspira Women's Health Inc. (company) — Registrant
- Dr. Carolann M. Small (person) — Appointed Chief Medical Officer
- Ms. Jennifer L. Good (person) — Elected to Board of Directors
- June 6, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer of Aspira Women's Health Inc.?
Dr. Carolann M. Small has been appointed as the new Chief Medical Officer.
Who has been elected to the Board of Directors of Aspira Women's Health Inc.?
Ms. Jennifer L. Good has been elected to the Board of Directors.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 6, 2024.
What other information is disclosed regarding company officers in this filing?
The filing also discloses compensatory arrangements for certain officers.
What is the state of incorporation for Aspira Women's Health Inc.?
Aspira Women's Health Inc. is incorporated in Delaware.
Filing Stats: 519 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2024-06-07 17:19:00
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share AWH Nasdaq Capital Market
- $375,000 — his annual base salary was increased to $375,000 from $325,000 as of June 1, 2024. The
- $325,000 — e salary was increased to $375,000 from $325,000 as of June 1, 2024. The foregoing des
Filing Documents
- awh-20240606.htm (8-K) — 57KB
- awh-ex10_1.htm (EX-10.1) — 21KB
- 0000950170-24-070892.txt ( ) — 203KB
- awh-20240606.xsd (EX-101.SCH) — 32KB
- awh-20240606_htm.xml (XML) — 5KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Second Amendment to Employment Agreement between Aspira Women's Health Inc. and Torsten Hombeck, dated June 6, 2024 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASPIRA WOMEN'S HEALTH INC. Date: June 7, 2024 By: /s/ Nicole Sandford Nicole Sandford Chief Executive Officer